Treatment-free remission after first-line dasatinib treatment in patients with chronic myeloid leukemia in the chronic phase: the D-NewS Study of the Kanto CML Study Group

Hiroki Yamaguchi, Naoki Takezako, Kazuteru Ohashi, Koji Oba, Takashi Kumagai, Yasuji Kozai, Hisashi Wakita, Koh Yamamoto, Akira Fujita, Tadahiko Igarashi, Chikashi Yoshida, Kazuma Ohyashiki, Shinichiro Okamoto, Junichi Sakamoto, Hisashi Sakamaki, Koiti Inokuchi

Research output: Contribution to journal › Article › peer-review

8 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Treatment-free remission after first-line dasatinib treatment in patients with chronic myeloid leukemia in the chronic phase: the D-NewS Study of the Kanto CML Study Group'. Together they form a unique fingerprint.

Medicine & Life Sciences